Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program
LIFE-SCREEN
Development and Evaluation of a Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program
1 other identifier
interventional
500
1 country
1
Brief Summary
The investigators propose a randomized controlled trial to develop and evaluate the impact of promoting advice on diet and lifestyle recommendations for cancer prevention at colorectal cancer screening among individuals who may be at higher risk for colorectal cancer (CRC). The specific objectives of this study are to 1) develop a lifestyle intervention based on evidenced-based diet and lifestyle recommendations (i.e. those proposed by the World Cancer Research Fund (WCRF) and the French National Cancer Institute); 2) evaluate the effect of the intervention on the adherence to the target diet and lifestyle recommendations as well as other subjective health measures, including quality of life; 3) evaluate the effect of the intervention on biological pathways linked to colorectal cancer development including physical fitness, anthropometrics, biomarkers for nutrition, and metabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Mar 2022
Typical duration for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2019
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedStudy Start
First participant enrolled
March 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedOctober 3, 2023
October 1, 2023
2.2 years
August 30, 2019
October 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in knowledge score assessed via a knowledge questionnaire
The knowledge regarding the effect of lifestyle factors on cancer risk and cancer prevention lifestyle recommendations will be assessed via a knowledge score derived from the General Nutrition \& Physical Activity Knowledge Questionnaires
1 year
Improvement in lifestyle score assessed via lifestyle questionnaires
WCRF lifestyle score will be assessed through lifestyle questionnaires. Compliance with the WCRF recommendations is considered achieved if this WCRF lifestyle score increases to more than 5 out of 8. The following questionnaires will be used to assess lifestyle changes: French EPIC food frequency questionnaire; the International Physical Activity Questionnaires - IPAQ; Weight and height measurements to assess BMI.
1 year
Study Arms (2)
Intervention
ACTIVE COMPARATORColorectal cancer free participants receive evidence-based diet and lifestyle advice in addition to the 'usual care' following a positive FIT test and diagnostic colonoscopy
Control
NO INTERVENTIONColorectal cancer free participants receive the 'usual care' following a positive FIT test and diagnostic colonoscopy
Interventions
Participants will be recruited during CRC screening and will be included if they have a positive faecal immunochemical test (FIT) and are diagnosed with adenomas but are CRC negative during the colonoscopy. Participants receive evidence-based diet and lifestyle advice intervention with 'usual care'.
Eligibility Criteria
You may qualify if:
- At high risk for CRC but CRC negative (confirmed by colonoscopy)
- Able to provide informed consent
- Understanding and able to speak French
You may not qualify if:
- Extensive intestinal surgery such as colectomy or surgical resection of the colon
- Chronic gastrointestinal illness (inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease)
- Use of any systemic antibiotics, antifungals, antivirals, or antiparasitics in the past 3 months
- Use of probiotic medications in the past 3 months
- Under a strict diet such as meal replacements, diets for co-morbidities such as diabetes
- Immobile due to physical constraints (e.g. handicap that is not compatible with physical activities)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- International Agency for Research on Cancerlead
- Centre Leon Berardcollaborator
- Hôpital Edouard Herriotcollaborator
- University of Bordeauxcollaborator
Study Sites (1)
International Agency for Research on Cancer
Lyon, Rhone, 69008, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc J Gunter, PhD
International Agency for Research on Cancer
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2019
First Posted
February 6, 2020
Study Start
March 23, 2022
Primary Completion
May 31, 2024
Study Completion
December 31, 2024
Last Updated
October 3, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share